Richard Söll
Richard Söll publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Chronic Myeloid Leukemia Treatments, Chemical Synthesis and Analysis and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #2,826,347 of 7,710,434 ranked researchers
- Rank in China
- #444,053 of 978,568
- Works
- 119
- Citations
- 5.2k
- Citations per work
- 43.9
What does Richard Söll research?
Richard Söll's work is mostly in Medicine (21%), Chemistry (19%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4436.7%
- Life Sciences2723.1%
- Health Sciences2521.3%
- Medicine2521.3%
- Physical Sciences2218.9%
- Chemistry2218.9%
- 1Organic Chemistry19% of their works
- 2Molecular Biology18% of their works
- 3Oncology8% of their works
- 4Hematology7% of their works
- 5Genetics6% of their works
- 6Immunology5% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Chemical Synthesis and Analysis
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cytokine Signaling Pathways and Interactions
- Retinal Diseases and Treatments
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
- Quinazolinone synthesis and applications
Which keywords describe Richard Söll's research?
The keywords of their largest research topics: Drug Discovery, Inflammation, BCR-ABL, Imatinib, Foldamers, Peptide Synthesis, Biological Evaluation and JAK2 Mutation.
- Quinoxaline
- Indirubin
- Click Chemistry
- Retinal Pigment Epithelium
- STAT3
- Synthesis
- JAK2 Mutation
- Peptide Synthesis
- Imatinib
- Inflammation
- Drug Discovery
- BCR-ABL
- Foldamers
- Biological Evaluation
- Myelofibrosis
- IL-6
- Macular Degeneration
- Antimicrobial Activity
- Copper-Catalyzed Cycloaddition
- Quinazoline
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Drug Discovery222 topics
- Inflammation202 topics
- BCR-ABL161 topic
- Imatinib161 topic
- Foldamers151 topic
- Peptide Synthesis151 topic
- Biological Evaluation142 topics
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- Synthesis142 topics
- IL-6111 topic
- STAT3111 topic
- Macular Degeneration91 topic
- Retinal Pigment Epithelium91 topic
- Antimicrobial Activity71 topic
- Click Chemistry71 topic
- Copper-Catalyzed Cycloaddition71 topic
- Indirubin71 topic
- Quinazoline71 topic
- Quinoxaline71 topic
Where does Richard Söll work?
Richard Söll's main affiliation in the publication record is WuXi AppTec (China), China.
How many publications and citations does Richard Söll have?
OpenAlex counts 119 works and 5,225 citations for Richard Söll, an h-index of 28, ranking #2,826,347 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Richard Söll. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.